Increasing prevalence of chronic diseases and rising demand for the point-of-care testing has encouraged market growth by 2030, States MRFR Report

Pune, India, December, 2022/MRFR Press Release/- Market Research Future published a Cooked research report on “Global Urinalysis Test Market Research Report - Forecast to 2030”– Market Analysis, Scope, Trends and Forecast to 2030

Competitive Analysis

There are numerous players operating in this market all over the globe. Many organizations especially in America, Europe and Asia region have their own manufacturing units. While some organizations outsource their facility of manufacturing to other organizations. Now-a-days, there is a significant increase in the number of the companies offering urinalysis test. Some of the major companies are trying to focus on new and advanced tests & products to gain the market. Whereas, some are has used the technique of acquisition and collaboration to gain the market. The major players like Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., ARKRAY, Inc., Siemens AG, held more than 45% of the global urinalysis test market, in 2016.

The key players profiled in urinalysis test are Dahaner (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc.  (U.S.), Siemens AG (U.S.), ARKRAY, Inc. (Japan), Sysmex Corporation (Japan), and ACON Laboratories, Inc. (U.S.).

Latest Industry Updates

Being a competitive market, a number of different manufacturer are focusing on the product launch, and acquisition for the market development. Some of the latest development in the market are-

June 2017: Roche, a Swiss company working in a pharmaceutical and diagnostic division acquired mySugr to form a leading platform for digital diabetes management.

 Jan 2016: Sysmex Corporation entered into a business alliance with EIKEN CHEMICAL CO., LTD to expand the urine analyzers market.

May 2017: ACON Laboratories, manufacturer of a broad array of high quality medical diagnostic and healthcare products, announced FDA clearance of the Mission Microalbumin/Creatinine Urine Reagent Strips.

Automation in healthcare sector has boosted the quality of the treatment. Automated urinalysis has gained a huge attention during last decade, thus a number of major manufacturer are focusing on the development of the new and digital devices.

Explore In-depth Details: Urinalysis Test Market Research Report

 Global Urinalysis Test Market – Overview

Urinalysis is the urine test used in the diagnosis and monitoring of number of diseases such as kidney disease and diabetes. The test is mostly recommended during pregnancy to determine the levels of hormone called human chorionic gonadotropin. Therefore, the demand for these test instruments and devices are growing across the globe. With the growing awareness of early diagnosis, technologically advanced products and rising need for non-invasive diagnosis to treat the various health disorders among the patients and healthcare professionals has supported the growth of the market. The increasing prevalence of various chronic diseases related to kidney, liver, and diabetes has spurred the growth of the urinalysis test market. However, strict regulations and lack of trained professionals may slow the growth of the market.

During the last decade, there is a significant development in the technology and the diagnostic treatment available for the diseases. The innovation in diagnostic devices is rapidly evolving and is receiving attention in clinical application. The trend is driven by an approach towards outcome based delivery practices in point of care testing. Numerous advantages offered by these devices and instruments such as easy diagnosis, painless procedures, and quality care further lead to their extensive use by the healthcare providers and preference by the patients. Technologies for monitoring blood glucose, HbA1c, cholesterol, blood gas and electrolyte, drugs of abuse, infectious diseases, pregnancy, and urinalysis are found to be evolving across the globe. The concept of connected healthcare has a tremendous impact on the growth of urinalysis test market. However, patents and brand recognition are major aspects governing the trends in the market

Regional Analysis

Regionally, the global urinalysis test market is segmented into: Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounts for the major share of the market owing to the increasing prevalence of urinary diseases, and diabetes. Additionally, availability of huge investment in research sector and increasing government support have fuelled the growth of the market. Europe commands the second largest share of market owing to increase demand for advanced diagnostic methods for the monitoring of diseases. Europe urinalysis test market has observed stable growth owing to increasing demand for advanced molecular diagnostic products. Asia-Pacific is fastest growing market region for this market due to presence of huge patient pool, and huge opportunity for the market growth. The Middle East and Africa holds the least share in the market due to lack of awareness among the people and lack of trained professionals to perform the urinalysis testing.